Ownership

Jill Marie Broadfoot - Chief Financial Officer at aTYR PHARMA INC

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Financial Officer
Stock Symbol: ATYR on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Jill Marie Broadfoot - trading volume in the past year for aTYR PHARMA INC

	Shares	%	Avg Price	Total $
Buys	+5K	79.9%	$1.79	+$8.95K
Sells	-1.25K	20.1%	$3.78	-$4.74K
Net	+3.75K	59.9%		+$4.21K

Showing 1 to 3 of 3 entries

Holdings reported by Jill Marie Broadfoot for aTYR PHARMA INC

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	31.8K	$120K	$3.78	Feb 4, 2025	Direct
Restricted Stock Unit	3.75K	$14.2K	$3.78	Feb 3, 2025	Direct	Common Stock
Restricted Stock Unit	7.5K	$8.84K	$1.18	Feb 5, 2024	Direct	Common Stock
Employee Stock Option (right to buy)	275K			Jan 8, 2025	Direct	Common Stock

Transactions reported by Jill Marie Broadfoot for aTYR PHARMA INC

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.